4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-22-012216
Options or other derivatives
- President & CEO acquired 87,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Hirsch Andrew President & CEO | 2022-02-23 | Grant or award · Performance Restricted Stock Units | +87,500 | 87,500 | D | ||
Loading xslF345X03/doc4.xml…